Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 28

1.

Decreased accumulation of subgenomic RNA in human cells infected with vaccine candidate DEN4Δ30 increases viral susceptibility to type I interferon.

Bustos-Arriaga J, Gromowski GD, Tsetsarkin KA, Firestone CY, Castro-Jiménez T, Pletnev AG, Cedillo-Barrón L, Whitehead SS.

Vaccine. 2018 Jun 7;36(24):3460-3467. doi: 10.1016/j.vaccine.2018.04.087. Epub 2018 May 8.

PMID:
29752023
2.

Genetic Determinants of Japanese Encephalitis Virus Vaccine Strain SA14-14-2 That Govern Attenuation of Virulence in Mice.

Gromowski GD, Firestone CY, Whitehead SS.

J Virol. 2015 Jun;89(12):6328-37. doi: 10.1128/JVI.00219-15. Epub 2015 Apr 8.

3.

Genetic and phenotypic properties of vero cell-adapted Japanese encephalitis virus SA14-14-2 vaccine strain variants and a recombinant clone, which demonstrates attenuation and immunogenicity in mice.

Gromowski GD, Firestone CY, Bustos-Arriaga J, Whitehead SS.

Am J Trop Med Hyg. 2015 Jan;92(1):98-107. doi: 10.4269/ajtmh.14-0427. Epub 2014 Oct 13.

4.

Japanese encephalitis virus vaccine candidates generated by chimerization with dengue virus type 4.

Gromowski GD, Firestone CY, Hanson CT, Whitehead SS.

Vaccine. 2014 May 23;32(25):3010-8. doi: 10.1016/j.vaccine.2014.03.062. Epub 2014 Mar 31.

5.

La Crosse virus infectivity, pathogenesis, and immunogenicity in mice and monkeys.

Bennett RS, Cress CM, Ward JM, Firestone CY, Murphy BR, Whitehead SS.

Virol J. 2008 Feb 11;5:25. doi: 10.1186/1743-422X-5-25.

6.
7.

Genetically modified, live attenuated dengue virus type 3 vaccine candidates.

Blaney JE Jr, Hanson CT, Firestone CY, Hanley KA, Murphy BR, Whitehead SS.

Am J Trop Med Hyg. 2004 Dec;71(6):811-21.

PMID:
15642976
8.

Mutations which enhance the replication of dengue virus type 4 and an antigenic chimeric dengue virus type 2/4 vaccine candidate in Vero cells.

Blaney JE Jr, Manipon GG, Firestone CY, Johnson DH, Hanson CT, Murphy BR, Whitehead SS.

Vaccine. 2003 Oct 1;21(27-30):4317-27.

PMID:
14505914
9.

Genetic basis of attenuation of dengue virus type 4 small plaque mutants with restricted replication in suckling mice and in SCID mice transplanted with human liver cells.

Blaney JE Jr, Johnson DH, Manipon GG, Firestone CY, Hanson CT, Murphy BR, Whitehead SS.

Virology. 2002 Aug 15;300(1):125-39.

11.
12.
13.
14.

Recombinant respiratory syncytial virus bearing a deletion of either the NS2 or SH gene is attenuated in chimpanzees.

Whitehead SS, Bukreyev A, Teng MN, Firestone CY, St Claire M, Elkins WR, Collins PL, Murphy BR.

J Virol. 1999 Apr;73(4):3438-42.

15.
16.

Monoclonal antibody-resistant mutants selected with a respiratory syncytial virus-neutralizing human antibody fab fragment (Fab 19) define a unique epitope on the fusion (F) glycoprotein.

Crowe JE, Firestone CY, Crim R, Beeler JA, Coelingh KL, Barbas CF, Burton DR, Chanock RM, Murphy BR.

Virology. 1998 Dec 20;252(2):373-5.

18.

Recombinant respiratory syncytial virus (RSV) bearing a set of mutations from cold-passaged RSV is attenuated in chimpanzees.

Whitehead SS, Juhasz K, Firestone CY, Collins PL, Murphy BR.

J Virol. 1998 May;72(5):4467-71.

19.
20.

Live subgroup B respiratory syncytial virus vaccines that are attenuated, genetically stable, and immunogenic in rodents and nonhuman primates.

Crowe JE Jr, Bui PT, Firestone CY, Connors M, Elkins WR, Chanock RM, Murphy BR.

J Infect Dis. 1996 Apr;173(4):829-39.

PMID:
8603960
22.

A cold-passaged, attenuated strain of human respiratory syncytial virus contains mutations in the F and L genes.

Connors M, Crowe JE Jr, Firestone CY, Murphy BR, Collins PL.

Virology. 1995 Apr 20;208(2):478-84.

25.
27.

Supplemental Content

Loading ...
Support Center